These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 8004848

  • 1. Nephrocalcinosis in X-linked hypophosphataemic rickets: its relationship to treatment, kidney function, and growth.
    Kooh SW, Binet A, Daneman A.
    Clin Invest Med; 1994 Apr; 17(2):123-30. PubMed ID: 8004848
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Therapeutics of X-linked hypophosphatemic rickets.
    Latta K, Hisano S, Chan JC.
    Pediatr Nephrol; 1993 Dec; 7(6):744-8. PubMed ID: 8130097
    [Abstract] [Full Text] [Related]

  • 5. X linked hypophosphataemia: treatment, height gain, and nephrocalcinosis.
    Reusz GS, Hoyer PF, Lucas M, Krohn HP, Ehrich JH, Brodehl J.
    Arch Dis Child; 1990 Oct; 65(10):1125-8. PubMed ID: 2248503
    [Abstract] [Full Text] [Related]

  • 6. Calcimimetics as an adjuvant treatment for familial hypophosphatemic rickets.
    Alon US, Levy-Olomucki R, Moore WV, Stubbs J, Liu S, Quarles LD.
    Clin J Am Soc Nephrol; 2008 May; 3(3):658-64. PubMed ID: 18256372
    [Abstract] [Full Text] [Related]

  • 7. Nephrocalcinosis is associated with renal tubular acidosis in children with X-linked hypophosphatemia.
    Seikaly M, Browne R, Baum M.
    Pediatrics; 1996 Jan; 97(1):91-3. PubMed ID: 8545232
    [Abstract] [Full Text] [Related]

  • 8. Nephrocalcinosis in children and adolescents: sonographic evaluation during long-term treatment with 1,25-dihydroxycholecalciferol.
    Weber G, Cazzuffi MA, Frisone F, de Angelis M, Pasolini D, Tomaselli V, Chiumello G.
    Child Nephrol Urol; 1996 Jan; 9(5):273-6. PubMed ID: 2856045
    [Abstract] [Full Text] [Related]

  • 9. Evidence suggesting hyperoxaluria as a cause of nephrocalcinosis in phosphate-treated hypophosphataemic rickets.
    Reusz GS, Latta K, Hoyer PF, Byrd DJ, Ehrich JH, Brodehl J.
    Lancet; 1990 May 26; 335(8700):1240-3. PubMed ID: 1971321
    [Abstract] [Full Text] [Related]

  • 10. Acute biochemical effects of growth hormone treatment compared with conventional treatment in familial hypophosphataemic rickets.
    Patel L, Clayton PE, Brain C, Pelekouda E, Addison GM, Price DA, Mughal MZ.
    Clin Endocrinol (Oxf); 1996 Jun 26; 44(6):687-96. PubMed ID: 8759181
    [Abstract] [Full Text] [Related]

  • 11. Metabolic and histologic investigation of the nature of nephrocalcinosis in children with hypophosphatemic rickets and in the Hyp mouse.
    Alon U, Donaldson DL, Hellerstein S, Warady BA, Harris DJ.
    J Pediatr; 1992 Jun 26; 120(6):899-905. PubMed ID: 1317418
    [Abstract] [Full Text] [Related]

  • 12. Nocturnal hyperparathyroidism: a frequent feature of X-linked hypophosphatemia.
    Carpenter TO, Mitnick MA, Ellison A, Smith C, Insogna KL.
    J Clin Endocrinol Metab; 1994 Jun 26; 78(6):1378-83. PubMed ID: 8200940
    [Abstract] [Full Text] [Related]

  • 13. Guide-lines to the treatment of patients with X-linked hypophosphatemic rickets.
    Reusz GS.
    Acta Biomed Ateneo Parmense; 1995 Jun 26; 66(3-4):147-51. PubMed ID: 8578931
    [Abstract] [Full Text] [Related]

  • 14. Hereditary hypophosphatemic rickets with hypercalciuria: case report.
    Areses-Trapote R, López-García JA, Ubetagoyena-Arrieta M, Eizaguirre A, Sáez-Villaverde R.
    Nefrologia; 2012 Jul 17; 32(4):529-34. PubMed ID: 22806288
    [Abstract] [Full Text] [Related]

  • 15. Growth in children with X-linked hypophosphataemic rickets.
    Verge CF, Cowell CT, Howard NJ, Donaghue KC, Silink M.
    Acta Paediatr Suppl; 1993 Mar 17; 388():70-5; discussion 76. PubMed ID: 8329834
    [Abstract] [Full Text] [Related]

  • 16. Long-term influence of calcitriol (1,25-dihydroxyvitamin D) and supplemental phosphate in X-linked hypophosphatemic rickets.
    Chesney RW, Mazess RB, Rose P, Hamstra AJ, DeLuca HF, Breed AL.
    Pediatrics; 1983 Apr 17; 71(4):559-67. PubMed ID: 6300745
    [Abstract] [Full Text] [Related]

  • 17. Nephrocalcinosis in X-linked hypophosphatemia: effect of treatment versus disease.
    Taylor A, Sherman NH, Norman ME.
    Pediatr Nephrol; 1995 Apr 17; 9(2):173-5. PubMed ID: 7794712
    [Abstract] [Full Text] [Related]

  • 18. Calcitriol treatment in vitamin D-dependent and vitamin D-resistant rickets.
    Glorieux FH.
    Metabolism; 1990 Apr 17; 39(4 Suppl 1):10-2. PubMed ID: 2157942
    [Abstract] [Full Text] [Related]

  • 19. The combined use of intravenous and oral calcium for the treatment of vitamin D dependent rickets type II (VDDRII).
    al-Aqeel A, Ozand P, Sobki S, Sewairi W, Marx S.
    Clin Endocrinol (Oxf); 1993 Aug 17; 39(2):229-37. PubMed ID: 8396512
    [Abstract] [Full Text] [Related]

  • 20. Risk factors affecting the development of nephrocalcinosis, the most common complication of hypophosphatemic rickets.
    Keskin M, Savaş-Erdeve Ş, Sağsak E, Çetinkaya S, Aycan Z.
    J Pediatr Endocrinol Metab; 2015 Nov 01; 28(11-12):1333-7. PubMed ID: 26203600
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.